Carina Biotech

Carina Biotech is an Australian preclinical immunotherapy company focused on researching and developing Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of solid cancers. CAR-T therapy is a revolutionary new treatment that harnesses the patient's immune system to fight cancer.Carina is developing CAR-T and other adoptive cell therapies that can be used to treat solid cancers, which are tailored to individual patients and cause minimal off-tumor damage. Carina is also leveraging its proprietary platform to develop technologies that improve access to and infiltration of solid tumors, as well as enhance the manufacturing of CAR-T cells.